Skip to main content
. 2023 Feb 17;13:1086846. doi: 10.3389/fonc.2023.1086846

Figure 6.

Figure 6

Sensitivity analysis of DFS (A) and OS (B) in patients with AML. DFS, disease-free survival; OS, overall survival; AML, acute myeloid leukemia.